Hims & Hers Health, Inc.
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
HIMS$19.13-16.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In Thousands, Except Share and Per Share Data)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $228,616 | $220,584 |
| Short-term available-for-sale investments | 348,876 | 79,667 |
| Inventory | 80,128 | 64,427 |
| Prepaid expenses and other current assets | 110,018 | 31,153 |
| Total current assets | 767,638 | 395,831 |
| Restricted cash | — | 856 |
| Long-term available-for-sale investments | 351,263 | — |
| Goodwill | 278,325 | 112,728 |
| Property, equipment, and software, net | 311,930 | 82,083 |
| Intangible assets, net | 196,116 | 43,410 |
| Operating lease right-of-use assets | 137,046 | 10,881 |
| Deferred tax assets, net | 82,707 | 61,603 |
| Other long-term assets | 29,680 | 147 |
| Total assets | $2,154,705 | $707,539 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $143,278 | $91,180 |
| Accrued liabilities | 78,518 | 53,013 |
| Deferred revenue | 127,160 | 75,285 |
| Earn-out payable | 46,986 | — |
| Earn-out liabilities | 3,646 | — |
| Operating lease liabilities | 4,843 | 1,889 |
| Total current liabilities | 404,431 | 221,367 |
| Convertible senior notes, net | 972,580 | — |
| Operating lease liabilities | 143,167 | 9,456 |
| Earn-out liabilities | 53,009 | — |
| Deferred tax liabilities, net | 28,856 | — |
| Other long-term liabilities | 11,734 | — |
| Total liabilities | 1,613,777 | 230,823 |
| Commitments and contingencies (Note 14) | ||
| Stockholders' equity: | ||
| Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 218,867,898 and 212,459,586 shares issued and outstanding as of December 31, 2025 and 2024, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of December 31, 2025 and 2024 | 23 | 22 |
| Additional paid-in capital | 652,383 | 719,155 |
| Accumulated other comprehensive income (loss) | 2,294 | (324) |
| Accumulated deficit | (113,772) | (242,137) |
| Total stockholders' equity | 540,928 | 476,716 |
| Total liabilities and stockholders' equity | $2,154,705 | $707,539 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.